Macquarie Group
FLGT icon

Macquarie Group’s Fulgent Genetics FLGT Stock Holding History

Macquarie Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-498
Closed -$32K – 1887
2022
Q3 		$32K Sell
498
-331
-40% -$16.6K ﹤0.01% 2066
2022
Q2 		$45K Hold
829
– – ﹤0.01% 2076
2022
Q1 		$52 Hold
829
– – ﹤0.01% 2129
2021
Q4 		$83K Hold
829
– – ﹤0.01% 1990
2021
Q3 		$75K Hold
829
– – ﹤0.01% 2077
2021
Q2 		$76K Buy
829
+498
+150% +$39.8K ﹤0.01% 2047
2021
Q1 		$32K Buy
331
+31
+10% +$3.2K ﹤0.01% 2174
2020
Q4 		$16K Buy
+300
New +$12.5K ﹤0.01% 2248
2020
Q2 		– Sell
-3,576
Closed -$38K – 2375
2020
Q1 		$38K Buy
+3,576
New +$49.8K ﹤0.01% 1843

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Macquarie Group's FLGT Position: Q4 2022 in Review

Macquarie Group sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 498 shares — an estimated $32K sold.

Macquarie Group first reported a position in FLGT in Q1 2020 and held it in 9 quarters. The position peaked at $83K in Q4 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Macquarie Group reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 498 Fulgent Genetics shares in Q4 2022, an estimated $32K.
  • Macquarie Group first reported a position in Fulgent Genetics in Q1 2020 and held it in 9 quarters.
  • Macquarie Group's Fulgent Genetics position peaked at $83K in Q4 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.